ArticleMolecular biology reports2025
Prenatal genetic findings using karyotyping and chromosomal microarray analysis in the first-occurrence typical orofacial clefts.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundOrofacial clefts (OFCs), including cleft lip (CL), cleft palate (CP), and cleft lip and palate (CLP), are among the most common congenital anomalies. Prenatal genetic evaluation plays a critical role in guiding pregnancy management. This study aimed to evaluate genetic findings and pregnancy outcomes in first-occurrence fetal OFCs using conventional karyotyping and SNP array analysis.
methodsWe retrospectively reviewed 205 pregnancies diagnosed with first-occurrence OFCs between December 2010 and December 2024. Cases were categorized as non-syndromic or syndromic OFCs based on the presence of additional malformations. All cases underwent conventional karyotyping; 138 also underwent SNP array analysis. Pregnancy outcomes were obtained through medical records and follow-up.
resultsOf the 205 cases, 74.6% were classified as non-syndromic OFCs and 25.4% were syndromic OFCs. Chromosomal abnormalities were detected in 11.7% of all OFCs, all occurring within the syndromic group, representing 46.2% of syndromic cases. The most frequent abnormalities were trisomy 13 and trisomy 18. SNP array analysis detected additional four clinically significant CNVs, improving diagnostic yield, particularly in syndromic OFCs. The termination rate was significantly higher in syndromic OFCs (90.2%) compared to non-syndromic cases (25.5%). Follow-up data on subsequent pregnancies were obtained for 45 cases, and no recurrent OFCs were observed.
conclusionMost cases of first-occurrence OFCs are isolated and carry a low risk of chromosomal abnormalities. Genetic evaluation is particularly valuable in syndromic OFCs, where the likelihood of clinically significant chromosomal abnormalities is higher. The combined use of karyotyping and SNP array analysis enhances diagnostic accuracy and provides important guidance for pregnancy management.
Indexed as
Identifiers
40762718What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.